Role of endothelial progenitor cells in the beneficial effects of physical exercise on atherosclerosis and coronary artery disease

2011 ◽  
Vol 111 (1) ◽  
pp. 321-328 ◽  
Author(s):  
Karsten Lenk ◽  
Madlen Uhlemann ◽  
Gerhard Schuler ◽  
Volker Adams

In clinical trials as well as in several animal experiments it is evident that physical exercise is a powerful tool to positively influence the development and/or progression of atherosclerosis and coronary artery disease (CAD). The main target of physical exercise seems to be the maintenance of an intact endothelial cell layer. Since the discovery that endothelial progenitor cells (EPCs) are present in the circulation and the knowledge that exercise, either as a single exercise bout or an exercise training program, have the potency to mobilize EPCs from the bone marrow, the contribution of the EPCs for the preservation or repair of the endothelial cell layer is still under debate. Either the EPCs differentiate into mature endothelial cells, or they stimulate via a paracrine mechanism mature endothelial cells to proliferate. It is still unclear, if the exercise-induced mobilization of EPCs is casually related to the improvement of endothelial function. This review will discuss the role of endothelial progenitor cells in the beneficial effects of physical exercise on atherosclerosis and coronary artery disease.

2013 ◽  
Vol 394 (10) ◽  
pp. 1241-1252 ◽  
Author(s):  
Michael Donahue ◽  
Cristina Quintavalle ◽  
Giovanni Alfonso Chiariello ◽  
Gerolama Condorelli ◽  
Carlo Briguori

Abstract In the last two decades a great deal of evidence has been collected on the key role of endothelial progenitor cells (EPC) in the mechanisms of vascular healing. The role of EPC as a marker of vascular health and prognosis of cardiovascular disease is already consolidated. This review aims to examine and evaluate recent data regarding EPC, as biomarkers, prognostic factor and potential therapy in cardiovascular disease.


2021 ◽  
Vol 13 (2) ◽  
pp. 106-13
Author(s):  
Yudi Her Oktaviono ◽  
Suryo Ardi Hutomo ◽  
Kevin Luke

BACKGROUND: Coronary artery disease (CAD) remains as the world number one cause of morbidity and mortality. Endothelial progenitor cells (EPCs) are known to be involved in vascular biology. Current review briefly summarizes the basics of EPCs and its clinical use in CAD.CONTENT: EPCs were firstly isolated in 1997 and involved in neovascularization. Further evidence defined EPCs into two distinguishable groups, namely: myeloid angiogenic cells (MACs) and endothelial colony forming cells (ECFCs). Common cardiovascular drugs, statin, angiotensin-converting enzyme (ACE) inhibitor, and their combinations, showed beneficial effects on EPCs. Likewise, the incorporation of EPCs upon CAD intervention management had been recently studied. Intramyocardial EPCs implementation and anti-CD34 antibody-coated stents could provide a promising option for refractory symptoms in CAD.SUMMARY: Association between EPCs and CAD is very dynamic and complex. EPCs could serve as both therapeutic target and agent in CAD patients. Subsequently, a universal definition of EPCs is needed for greater research in the future.KEYWORDS: atherosclerosis, coronary artery disease, endothelial progenitor cells, neovascularization


2013 ◽  
Vol 61 (10) ◽  
pp. E1139
Author(s):  
Niccolò Mancini ◽  
Chrysanthos Grigoratos ◽  
Maria Elena Lucia Picoi ◽  
Federica Massaro ◽  
Tatiana Santoni ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document